| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.00094 | 1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.00084 | 1 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.00041 | 1 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.001 | 1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.00026 | 1 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.00019 | 1 |